Watchful Waiting in BCC: Which Patients Can Benefit? Watchful Waiting in BCC: Which Patients Can Benefit?
Some patients with basal cell carcinoma (BCC) may not need treatment. New data reveal who those patients likely are.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 20, 2021 Category: Surgery Tags: Hematology-Oncology News Source Type: news

New Drug Might Be Non-Surgical Option for Common Skin Cancers
An experimental gel could be a potential alternative to surgery when treating basal cell carcinoma. (Source: WebMD Health)
Source: WebMD Health - August 9, 2021 Category: Consumer Health News Source Type: news

Remetinostat Gel Promising for Basal Cell Carcinoma
Overall response rate of 69.7 percent seen with topical HDAC inhibitor; complete resolution observed for 54.8 percent of tumors on pathologic exam (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 6, 2021 Category: Cancer & Oncology Tags: Dermatology, Oncology, Pharmacy, Journal, Source Type: news

Remetinostat Gel Promising for Basal Cell Carcinoma
FRIDAY, Aug. 6, 2021 -- The histone deacetylase (HDAC) inhibitor remetinostat may be effective for reducing the disease burden of basal cell carcinoma (BCC), according to a study published online Aug. 6 in Clinical Cancer Research. James M.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 6, 2021 Category: Pharmaceuticals Source Type: news

Coffee protects against liver cancer while alcohol is linked with numerous cancers
Alcohol consumption is a major risk factor for several cancers including head & neck (mouth, pharynx, larynx), oesophageal and bowel cancer - as well as the more widely known links to breast and liver cancer - according to a new study funded by World Cancer Research Fund (WCRF)(1), and published this week in Nature Communications. The study also found increased coffee consumption was associated with a lower risk of developing liver cancer and basal cell carcinoma of the skin. (Source: World Pharma News)
Source: World Pharma News - August 4, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Metformin Use May Curb BCC Risk Metformin Use May Curb BCC Risk
The decrease in basal cell carcinoma (BCC) risk was seen across all metformin dosing levels, but the reason for this remains unclear.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 15, 2021 Category: Cancer & Oncology Tags: Dermatology News Source Type: news

Consumer Health: UV radiation and your skin
July is UV Safety Month, which makes this a good time to learn more about the harmful effects of ultraviolet, or UV, radiation from sunlight or tanning beds. Skin cancer is the most common type of cancer, according to the American Cancer Society. Skin cancer develops primarily on areas of sun-exposed skin, including the scalp, face, lips, ears, neck, chest, arms, hands and legs.  The three main types of skin cancer are basal cell carcinoma, squamous cell carcinoma and melanoma.… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 4, 2021 Category: Databases & Libraries Source Type: news

EU Panel Likes Monotherapy Cemiplimab for Two Cancers EU Panel Likes Monotherapy Cemiplimab for Two Cancers
In Europe, the Committee for Medicinal Products for Human Use (CHMP) adopted positive opinions for cemiplimab as monotherapy in lung cancer and basal cell carcinoma.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 25, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Cancer symptoms: How to identify skin cancer when it is a squamous cell carcinoma
CANCER of the skin can fall into two categories: basal cell carcinoma and squamous cell carcinoma , with the latter being more dangerous. SCCs can become invasive, growing into deep layers of the skin and can metastasise. (Source: Daily Express - Health)
Source: Daily Express - Health - May 23, 2021 Category: Consumer Health News Source Type: news

Cancer symptoms: The appearance of skin cancer to look out for – basal cell carcinoma
CANCER may develop on skin exposed to the sun, especially on the face, head and neck. Slow-growing basal cell carcinoma can have a distinctive appearance. Find out what to look out for at Express.co.uk. (Source: Daily Express - Health)
Source: Daily Express - Health - May 22, 2021 Category: Consumer Health News Source Type: news

Biopsy Outperforms RCM in Diagnosing and Subtyping BCC Biopsy Outperforms RCM in Diagnosing and Subtyping BCC
This study investigated whether a correct diagnosis and subtype could be determined using reflectance confocal microscopy in patients with a clinically suspected primary basal cell carcinoma.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 6, 2021 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Janssen Announces U.S. FDA Approval of PONVORY ™ (ponesimod), an Oral Treatment for Adults with Relapsing Multiple Sclerosis Proven Superior to Aubagio® (teriflunomide) in Reducing Annual Relapses and Brain Lesions
TITUSVILLE, N.J. – (March 19, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.1,2,3 PONVORY™ offers MS patients superior efficacy in reducing annualized relapse rates compared to an established oral therapy and a proven safety profi...
Source: Johnson and Johnson - March 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Cemiplimab Now Approved for Basal Cell Carcinoma Cemiplimab Now Approved for Basal Cell Carcinoma
The FDA has approved the immunotherapy for patients with locally advanced or metastatic basal cell carcinoma previously treated with a hedgehog pathway inhibitor or for whom an HHI is inappropriate.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 10, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

FDA Approves Libtayo (cemiplimab-rwlc) as First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma
TARRYTOWN, N.Y. and PARIS, Feb. 9, 2021 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) approved the PD-1 inhibitor Libtayo (cemiplimab-rwlc) as the... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 9, 2021 Category: Drugs & Pharmacology Source Type: news

Expert Offers Tips for Sorting Out Pink Lesions on Dermoscopy Expert Offers Tips for Sorting Out Pink Lesions on Dermoscopy
"How can dermoscopy help us distinguish between Spitz nevus, melanoma, clear cell acanthoma, psoriasis, basal cell carcinoma, and squamous cell carcinoma?"Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 2, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Skin cancer: Main symptoms to look out for warning of basal cell carcinoma
SKIN cancer is not only a condition one needs to worry about in the summertime. What are the main symptoms to look out for in basal cell carcinoma? (Source: Daily Express - Health)
Source: Daily Express - Health - January 12, 2021 Category: Consumer Health News Source Type: news

Skin cancer symptoms: Five warning signs of a basal cell carcinoma
SKIN CANCER can successfully be removed, without complications, with early detection and treatment. There are five warning signs of basal cell carcinoma. What are they? (Source: Daily Express - Health)
Source: Daily Express - Health - December 30, 2020 Category: Consumer Health News Source Type: news

Interventions for basal cell carcinoma of the skin
Why is this question important?Basal cell carcinoma (BCC) is the most common form of skin cancer among people with white skin.BCC is not usually life ‐threatening but if left untreated, it can cause important disfigurement, especially on the face.Surgical removal of the affected area and surrounding skin is usually the first option for treating BCC. Several different surgical approaches exist as well as non ‐surgical treatments, such as radiotherapy (high doses of radiation that kill cancer cells), and anti‐cancer creams, gels and ointments.We reviewed the evidence from research studies, to find out which treatments ...
Source: Cochrane News and Events - November 18, 2020 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Cemiplimab Shows Promise for Patients with Advanced Basal Cell Carcinoma
Cemiplimab showed clinically meaningful and durable responses in this group of patients for whom there are no currently approved treatments. (Source: CancerNetwork)
Source: CancerNetwork - May 6, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Recognizing BCC on Smartphone-captured Digital Histopathology Recognizing BCC on Smartphone-captured Digital Histopathology
A novel approach using deep neural network frameworks shows promise for the diagnosis of basal-cell carcinoma via a smartphone camera.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 10, 2020 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

How Mohs surgery is used to fight skin cancer: Mayo Clinic Radio Health Minute
Mohs surgery is used to treat the most common skin cancers, basal cell carcinoma and squamous cell carcinoma, as well as some kinds of melanoma. It's especially useful for skin cancers located in areas where it's important to preserve as much healthy skin as possible, such as around the eyes, ears, nose and mouth.  In [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 8, 2020 Category: Databases & Libraries Source Type: news

Clostridioides Difficile Management in a Patient With Barrett ’s Esophagus
Mrs. S is an 85-year-old woman who moved into the nursing home five years ago when her husband could no longer provide care for her due to her progressive weakness and failure to thrive. She has a history of Barrett ’s esophagus and significant reflux and subsequent dysphagia, a long history of depression, allergic rhinitis, dementia with a Brief Interview for Mental Status (BIMS) score of 12, basal cell carcinoma, insomnia, iron deficiency anemia, and a pneumonitis due to aspiration. She is oxygen dependent. (Source: Caring for the Ages)
Source: Caring for the Ages - March 31, 2020 Category: Health Management Authors: Barbara Resnick, Paige Hector Tags: Interdisciplinary Team Case Studies Source Type: news

Woman, 32, develops skin cancer from a chickenpox scar which was 27 years old
Louise Thorell, from Ashington in Northumberland, developed basal cell carcinoma and needed three surgeries to remove all the cancer from her right cheek. (Source: the Mail online | Health)
Source: the Mail online | Health - January 2, 2020 Category: Consumer Health News Source Type: news

ASTRO Releases Clinical Guideline for Radiation Therapy in Treating Patients with Skin Cancer
The recommendations defined when and how radiation therapy should be used to treat patients with basal cell carcinoma and cutaneous squamous cell carcinoma. (Source: CancerNetwork)
Source: CancerNetwork - December 31, 2019 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Clinical Guideline Released for Radiation Therapy in Treating Patients with Skin Cancer
Recommendations defined when and how radiation therapy should be used to treat patients with basal cell carcinoma and cutaneous squamous cell carcinoma. (Source: CancerNetwork)
Source: CancerNetwork - December 20, 2019 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Tanning addict, 50, claims an 'APP diagnosed her with skin cancer'
Susanna Hancock, 50, of Sale, Greater Manchester, downloaded the app SkinVision in January this year. She was later diagnosed with basal cell carcinoma and had the mole removed. (Source: the Mail online | Health)
Source: the Mail online | Health - August 27, 2019 Category: Consumer Health News Source Type: news

Teacher, 24, shocked after what she thought was pimple under her eye turned out to be skin cancer
Gibson Miller, 24, from New York City, was diagnosed with basal cell carcinoma in April 2019, after what she thought was pimple under her left eye turned out to be skin cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - July 31, 2019 Category: Consumer Health News Source Type: news

Skin cancer patient was left with a gaping golf ball-sized hole in her forehead
WARNING, GRAPHIC CONTENT: Keri Lynn Noble, from Cincinnati in Ohio, was told she had a basal cell carcinoma in 2016, after noticing an odd-looking scab on her forehead. (Source: the Mail online | Health)
Source: the Mail online | Health - July 24, 2019 Category: Consumer Health News Source Type: news

Having a close relative with melanoma could raise your risk of it by 74 per cent
Researchers from Indiana University studied the medical records of more than 200,000 people and found the risk of getting squamous or basal cell carcinoma also rose with family ties. (Source: the Mail online | Health)
Source: the Mail online | Health - July 16, 2019 Category: Consumer Health News Source Type: news

Mesothelioma Clinical Trial Exploring Family Predisposition
The National Cancer Institute has opened a clinical trial using mesothelioma patients and their family members to explore predisposition to the cancer and potential solutions to negating it. The trial is a follow up to an earlier study of a genetic mutation that creates susceptibility to various cancers but a longer-than-normal survival with platinum-based chemotherapy treatment. “This is an important, long-term study that could have implications not only for a patient, but for family members, too,” Dr. Raffit Hassan, NCI senior investigator told The Mesothelioma Center at Asbestos.com. “Progress can be m...
Source: Asbestos and Mesothelioma News - May 20, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Review Touts Benefits of Immunotherapy for Non-Melanoma Skin Cancers
The authors discuss the potential use and limitations of immunotherapy among patients with squamous cell cancer, basal cell carcinoma, and other skin cancers. (Source: CancerNetwork)
Source: CancerNetwork - May 3, 2019 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

Efficacy of One-Day Fractionated Photodynamic Therapy for Basal Cell Carcinoma
Researchers evaluated the response of patients with BCC to fractionated photodynamic therapy at 30 days after treatment. (Source: CancerNetwork)
Source: CancerNetwork - May 3, 2019 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

Basal Cell Carcinoma Subtype Reporting Varies by Practice, May Put Patients at Risk Basal Cell Carcinoma Subtype Reporting Varies by Practice, May Put Patients at Risk
Underreporting of basal cell carcinoma (BCC) subtypes occurs in academic, teaching and nonteaching institutions and may place patients at risk for inadequate or inappropriate therapy, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 26, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

OCT for Diagnosis of Basal Cell Carcinoma OCT for Diagnosis of Basal Cell Carcinoma
This review explores how optical coherence tomography, a noninvasive near-infrared light imaging technology, might improve the diagnosis and management of basal cell carcinoma.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 15, 2019 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Mayo Clinic Minute: 3 types of skin cancer
There's no questions that sun exposure increases your risk of skin cancer. ?Skin cancer is the most common type of cancer in the U.S., according to the Centers for Disease Control and Prevention.?Dr. Dawn Davis, a Mayo Clinic dermatologist, says there are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma and [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 7, 2019 Category: Databases & Libraries Source Type: news

Childhood Cancer Survivors at High Risk for Skin Malignancies Childhood Cancer Survivors at High Risk for Skin Malignancies
As adults, childhood cancer survivors have a 30-fold higher risk than the general population of developing basal cell carcinoma, a Dutch study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 11, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Childhood cancer survivors at high risk for skin malignancies
(Reuters Health) - As adults, childhood cancer survivors have a 30-fold higher risk than the general population of developing common skin malignancies known as basal cell carcinoma, a Dutch study suggests. (Source: Reuters: Health)
Source: Reuters: Health - March 8, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Super-enhancers: novel target for pancreatic ductal adenocarcinoma
(Rapamycin Press) Among many pathways of cancer progression that PDAC relies on, anomalous activation of the sonic hedgehog pathway has shown in a variety of human cancers, including, basal cell carcinoma, malignant gliomas, medulloblastoma, leukemias, and cancers of the breast, lung, pancreas, and prostate. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 26, 2019 Category: Cancer & Oncology Source Type: news

Targeted and Immune Therapeutics for Basal Cell Cancer Targeted and Immune Therapeutics for Basal Cell Cancer
Review the use of hedgehog pathway inhibitors and other novel treatment options for metastatic basal cell carcinoma.Annals of Oncology (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - February 4, 2019 Category: Radiology Tags: Hematology-Oncology Journal Article Source Type: news

Low-risk cancers should be renamed 'indolent', oncologist urges
Birte Twisselmann (pictured) - an editor at The BMJ - was reassured following her basal cell carcinoma diagnosis when a colleague said 'well, it ’s not really cancer - you won’t die from it'. (Source: the Mail online | Health)
Source: the Mail online | Health - January 23, 2019 Category: Consumer Health News Source Type: news

Topical Photodynamic Therapy for Basal Cell Carcinoma Topical Photodynamic Therapy for Basal Cell Carcinoma
How does topical photodynamic therapy compare in efficacy with other treatment options for low-risk basal cell carcinoma?The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 21, 2019 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Skin Cancer | Medscape Skin Cancer | Medscape
Nonmelanoma skin cancer primarily comprises basal cell carcinoma and squamous cell carcinoma. Other, rarer types of nonmelanoma skin cancer include dermatofibrosarcoma protuberans, Merkel cell carcinoma, and Kaposi's sarcoma. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 28, 2018 Category: Consumer Health News Tags: Resource Center Source Type: news

Senhwa Biosciences Silmitasertib filed IND of Basal Cell Carcinoma approved by FDA
TAIPEI, Taiwan and SAN DIEGO, Nov. 1, 2018 -- (Healthcare Sales & Marketing Network) -- Senhwa Biosciences Inc. (TPEx: 6492) announced today that FDA has approved its IND application for basal cell carcinoma (BCC). To accelerate the development of this ne... Biopharmaceuticals, Oncology, FDA Senhwa Biosciences, Silmitasertib, basal cell carcinoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 1, 2018 Category: Pharmaceuticals Source Type: news

Study: Best Treatments for Basal Cell Carcinoma
When treating low-risk primary basal cell carcinoma (BCC), surgery and external beam radiation yield a better chance of a cure and a lower recurrence rate compared with other treatment modalities. This is the finding of a recent meta-analysispublished in theAnnals of Internal Medicine. (Source: CancerNetwork)
Source: CancerNetwork - October 17, 2018 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

Pulse Biosciences launches NPS cutaneous wart feasibility study
Pulse Biosciences (NSDQ:PLSE) said today that it launched a clinical feasibility study of its Nano-Pulse Stimulation platform intended to treat cutaneous warts. The Nano-Pulse Stimulation system is a novel, non-thermal tech platform designed to deliver nanosecond duration energy pulses intended to disrupt functions of internal cell structures while maintaining outer cell membranes, the Hayward, Calif.-based company said. Pulse Biosciences said that the device’s mechanism of action has been shown in previous clinical studies to eliminate treated cells with only mild inflammatory response and favorable healin...
Source: Mass Device - October 11, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Cosmetic/Aesthetic Pulse Biosciences Source Type: news

Sparse Evidence to Select Optimal Treatment for Basal Cell Carcinoma Sparse Evidence to Select Optimal Treatment for Basal Cell Carcinoma
Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 21, 2018 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Review: Treatments for Primary Basal Cell Carcinoma Compared
Similarly low recurrence rates for excision, Mohs sx, curettage and diathermy, external - beam radiation (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 18, 2018 Category: Cancer & Oncology Tags: Dermatology, Oncology, Pathology, Journal, Source Type: news

Review: Treatments for Primary Basal Cell Carcinoma Compared
TUESDAY, Sept. 18, 2018 -- For patients with primary basal cell carcinoma (BCC), estimated recurrence rates are similarly low for excision, Mohs surgery, curettage and diathermy, and external-beam radiation, according to a review and meta-analysis... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 18, 2018 Category: Pharmaceuticals Source Type: news

A review of prevalent methods for automatic skin lesion diagnosis
(Bentham Science Publishers) The three prevalent skin cancers, according to the literature are melanoma, basal cell carcinoma and squamous cell carcinoma. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 15, 2018 Category: International Medicine & Public Health Source Type: news

Common skin cancer can signal increased risk of other cancers, Stanford researchers say
(Stanford Medicine) People who develop abnormally frequent cases of a skin cancer known as basal cell carcinoma appear to be at significantly increased risk for the development of other cancers, including blood, breast, colon and prostate cancers, according to a preliminary study by researchers at the Stanford University School of Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 9, 2018 Category: Cancer & Oncology Source Type: news